Vivek Kumar Singh

661 total citations
20 papers, 489 citations indexed

About

Vivek Kumar Singh is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Vivek Kumar Singh has authored 20 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Organic Chemistry. Recurrent topics in Vivek Kumar Singh's work include Chronic Myeloid Leukemia Treatments (4 papers), Curcumin's Biomedical Applications (3 papers) and Acute Myeloid Leukemia Research (2 papers). Vivek Kumar Singh is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Curcumin's Biomedical Applications (3 papers) and Acute Myeloid Leukemia Research (2 papers). Vivek Kumar Singh collaborates with scholars based in India, Taiwan and United States. Vivek Kumar Singh's co-authors include Mohane Selvaraj Coumar, Indira Ghosh, Hsing‐Pang Hsieh, Akhil C. Banerjea, P. Sankar, Larance Ronsard, Kumaravel Mohankumar, Rukkumani Rajagopalan, Yi-Yu Ke and Wen‐Hsing Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Vivek Kumar Singh

20 papers receiving 486 citations

Peers

Vivek Kumar Singh
Lixian Wu China
Keqin Kathy Li China
Nehru Viji Sankaranarayanan United States
José Navarro‐Fernández Spain
S. Lovell United States
Chia‐Hui Huang Taiwan
P. Brear United Kingdom
Yin Wu China
Mehul Patel United States
Meijuan Huang China
Lixian Wu China
Vivek Kumar Singh
Citations per year, relative to Vivek Kumar Singh Vivek Kumar Singh (= 1×) peers Lixian Wu

Countries citing papers authored by Vivek Kumar Singh

Since Specialization
Citations

This map shows the geographic impact of Vivek Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Kumar Singh more than expected).

Fields of papers citing papers by Vivek Kumar Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Kumar Singh. The network helps show where Vivek Kumar Singh may publish in the future.

Co-authorship network of co-authors of Vivek Kumar Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Kumar Singh. A scholar is included among the top collaborators of Vivek Kumar Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Kumar Singh. Vivek Kumar Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakral, Deepshi, Vivek Kumar Singh, Ritu Gupta, et al.. (2022). Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia. Annals of Hematology. 102(1). 73–87. 7 indexed citations
2.
Singh, Vivek Kumar, et al.. (2022). EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells. International Journal of Hematology. 117(1). 110–120. 4 indexed citations
3.
Singh, Vivek Kumar, Deepshi Thakral, & Ritu Gupta. (2021). Regulatory noncoding RNAs: potential biomarkers and therapeutic targets in acute myeloid leukemia.. PubMed. 11(5). 504–519. 11 indexed citations
4.
Singh, Vivek Kumar, et al.. (2021). EVI1 promotes metastasis by downregulating TIMP2 in metastatic colon and breast cancer cells. The International Journal of Biochemistry & Cell Biology. 142. 106118–106118. 4 indexed citations
5.
Kar, Rohan, Niraj Kumar Jha, Saurabh Kumar Jha, et al.. (2019). A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer. Genes. 10(12). 961–961. 68 indexed citations
6.
Singh, Vivek Kumar & Mohane Selvaraj Coumar. (2018). Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance. Mini-Reviews in Medicinal Chemistry. 19(4). 333–345. 17 indexed citations
7.
Singh, Vivek Kumar & Mohane Selvaraj Coumar. (2017). Ensemble-based virtual screening: identification of a potential allosteric inhibitor of Bcr-Abl. Journal of Molecular Modeling. 23(7). 218–218. 6 indexed citations
8.
Ronsard, Larance, Vivek Kumar Singh, Kumaravel Mohankumar, et al.. (2017). Impact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA Interaction. Frontiers in Microbiology. 8. 14 indexed citations
9.
Singh, Vivek Kumar, et al.. (2017). Invasive Haemophilus influenzae Infection in Patients with Cancer. Cancer Control. 24(1). 66–71. 9 indexed citations
10.
Nanjappa, Sowmya, et al.. (2017). Thrombotic Microangiopathy in a Patient Treated with Gemcitabine. Cancer Control. 24(1). 54–56. 4 indexed citations
11.
Singh, Vivek Kumar, Hsin-Huei Chang, Ching‐Chuan Kuo, et al.. (2016). Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors. Journal of Biomolecular Structure and Dynamics. 35(8). 1833–1848. 23 indexed citations
12.
Ke, Yi-Yu, Vivek Kumar Singh, Mohane Selvaraj Coumar, et al.. (2015). Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification. Scientific Reports. 5(1). 11702–11702. 64 indexed citations
13.
Mohankumar, Kumaravel, P. Sankar, Vivek Kumar Singh, et al.. (2015). BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway—A comparative study with curcumin. Biomedicine & Pharmacotherapy. 74. 178–186. 31 indexed citations
14.
Chhapekar, Sushil Satish, Ramakrishna Chopperla, Vivek Kumar Singh, et al.. (2014). Transgenic rice expressing a codon-modified synthetic CP4-EPSPS confers tolerance to broad-spectrum herbicide, glyphosate. Plant Cell Reports. 34(5). 721–731. 37 indexed citations
15.
Sarvagalla, Sailu, Vivek Kumar Singh, Yi-Yu Ke, et al.. (2014). Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity. Journal of Computer-Aided Molecular Design. 29(1). 89–100. 38 indexed citations
16.
Mohankumar, Kumaravel, P. Sankar, Vivek Kumar Singh, et al.. (2014). Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways. Cellular Oncology. 37(6). 439–454. 29 indexed citations
17.
Singh, Vivek Kumar & Indira Ghosh. (2013). Methylerythritol phosphate pathway to isoprenoids: Kinetic modeling andin silicoenzyme inhibitions inPlasmodium falciparum. FEBS Letters. 587(17). 2806–2817. 15 indexed citations
18.
Mohankumar, Kumaravel, P. Sankar, Vivek Kumar Singh, et al.. (2013). Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approach. Chemico-Biological Interactions. 210. 51–63. 52 indexed citations
19.
Singh, Vivek Kumar, et al.. (2012). Kinetic Modelling of GlmU Reactions – Prioritization of Reaction for Therapeutic Application. PLoS ONE. 7(8). e43969–e43969. 10 indexed citations
20.
Singh, Vivek Kumar & Indira Ghosh. (2006). Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets. Theoretical Biology and Medical Modelling. 3(1). 27–27. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixian Wu Breakdown of academic impact, for papers by Keqin Kathy Li Breakdown of academic impact, for papers by Nehru Viji Sankaranarayanan Breakdown of academic impact, for papers by José Navarro‐Fernández Breakdown of academic impact, for papers by S. Lovell Breakdown of academic impact, for papers by Chia‐Hui Huang Breakdown of academic impact, for papers by P. Brear Breakdown of academic impact, for papers by Yin Wu Breakdown of academic impact, for papers by Mehul Patel Breakdown of academic impact, for papers by Meijuan Huang
Rankless by CCL
2026